Likewise, ample evidence suggests that impaired hepatic SIRT1 and SIRT3 signaling contributes to NAFLD [183, 185–188, , , ] and that SIRT1 overexpression reverses hepatic steatosis [189, 190]. This evidence concerns the gene SIRT1 and fatty liver disease.